Texas

LATEST FROM BIOSPACE

Drug Development

May Was a Busy Month with Seven Biotech IPOs

There were seven initial public offerings (IPOs) for biotech companies in the month of May. Here’s a look.

June 1, 2021

4 min read

Mark Terry

Business

BioSpace Movers & Shakers, May 21

Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.

May 20, 2021

10 min read

Alex Keown

Bio NC

COVID-19 News: Test for Asymptomatic People, Bemcentinib in Hospitalized COVID-19 Patients and More

Please check out the biopharma industry’s COVID-19 stories that are trending for May 18, 2021.

May 18, 2021

5 min read

BioSpace Editorial Staff

Business

Caris Life Sciences Closes Whopping $830 Million Growth Equity Round

The company has raised approximately $1.3 billion in external financing over the past three years, including $310 million in 2020.

May 12, 2021

3 min read

Alex Keown

Bio NC

2021 COVID-19 News: India Variant a Global Concern, Low Risk of Serious Long Term Effects and More

Please check out the biopharma industry’s COVID-19 stories that are trending for May 11, 2021.

May 11, 2021

5 min read

BioSpace Editorial Staff

Bio NC

2021 COVID-19 News: Pfizer to File for Full Approval of Its Vaccine and More

Please check out the biopharma industry’s COVID-19 stories that are trending for May 4, 2021.

May 4, 2021

3 min read

BioSpace Editorial Staff

FDA

Houston’s Hope BioSciences Highlights Texas’ Hotbed Status

Texas is quickly becoming a hotbed of biopharmaceutical activities, with Houston being one of the two top cities in the state that is leading the way.

April 28, 2021

3 min read

Brandon May

Lone Star Bio

Sun’s Out to Play, But So Is Skin Cancer - Here’s What Pharma is Doing About It

There are several experimental treatments undergoing study for types of melanoma. BioSpace rounds up some of the most recent clinical news in this space.

April 27, 2021

4 min read

Alex Keown